Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of fumaric acid ester-PUVA versus PUVA-etretinate in palmoplantar pustulosis
2006-004519-23Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acitretin in Palmoplantar Pustular Psoriasis (PPPP) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Relapse-free patients at 9.5 months. Started Feb 2009; status: completed.
02
Drugs
acitretin
03
Conditions
Palmoplantar Pustular Psoriasis (PPPP)
Beyond the preview
Go deeper on 2006-004519-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004519-23.